Inactive Instrument

Company Zymergen Inc.

Equities

ZY

US98985X1000

Biotechnology & Medical Research

Business Summary

Zymergen Inc. integrates computational and manufacturing technologies to design, develop, and commercialize bio-based products in a range of industries. Its platform consists of three key capabilities: its collection of accessible biomolecules; its software and data science technology, and its data-driven microbe optimization processes. Its businesses include advanced materials, which seeks to employ bio-advantaged molecules or microbes to develop and deliver products and is focused on four markets: agriculture, water repellency, advanced polymers, and healthcare; drug discovery business leverages its differentiated access to natural products as a source of diverse chemical matter provided by its unified metagenomics database, and automation business, which offers automation technology to organizations involved in lab operations. Its software and data science platform informs, guides, and records its experiments forming the infrastructure for the learning cycle.

Number of employees: 505

Sales per Business

USD in Million2020Weight2021Weight Delta
Research and Development Service Agreements
74.1 %
10 73.7 % 12 74.1 % +26.83%
Collaboration
25.9 %
3 26.3 % 4 25.9 % +23.90%

Sales per region

USD in Million2020Weight2021Weight Delta
United States
40.6 %
6 45.9 % 7 40.6 % +11.32%
Europe
30.7 %
2 18.4 % 5 30.7 % +110.64%
Asia
28.7 %
5 35.7 % 5 28.7 % +1.37%

Managers

Managers TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Corporate Officer/Principal - 21-08-04
Corporate Officer/Principal - 21-08-04
Human Resources Officer - 17-02-28
Corporate Officer/Principal - 21-05-03
General Counsel 50 19-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 104,355,336 97,958,911 ( 93.87 %) 0 93.87 %

Company contact information

Zymergen, Inc.

27 Drydock Avenue 8th floor

02210, Boston

+415 801 8073

http://www.zymergen.com
address Zymergen Inc.(ZY)
  1. Stock Market
  2. Equities
  3. ZY Stock
  4. Company Zymergen Inc.